A Comparison of Outcomes for Younger and Older Adult Patients Undergoing Surgery for Primary Hyperparathyroidism
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In adolescents and young adults, primary hyperparathyroidism (PHPT) is an uncommon diagnosis. We compared the clinical characteristics of these patients to those of older adult patients with PHPT. We hypothesized that PHPT in adolescents and young adults is more often caused by single-gland disease and is amenable to minimally invasive parathyroidectomy (MIP).
We retrospectively reviewed the medical records of 452 consecutive patients who had surgery for PHPT. Patients ranged in age from 13 to 94 years and were dichotomized into younger (age <30 years, n = 17, 3.8%) and older (age ≥30 years, n = 435, 96.2%) patients. Continuous baseline and intraoperative and postoperative measures were not normally distributed and were summarized with medians and interquartile ranges (IQRs). Groups were compared using Wilcoxon rank sum test or Fisher exact test, and significance was set at P < .05.
Median [IQR] age was 24 [23–27] years for the younger group and 58 [51–66] years for the older group. Though not statistically significant, a smaller proportion of the younger patients compared with the older patients had a positive 99mTc-sestamibi scan (71%; 95% confidence interval [95% CI] = 44–90% vs. 83%; 95% CI = 79–86%) and showed a suspected parathyroid adenoma on ultrasound (65%; 95% CI = 38–86% vs. 80%; 95% CI = 76–83%). The younger and older age groups did not significantly differ on preoperative serum PTH levels (median [IQR]: 111 [76–145] pg/ml vs 110 [84–152] pg/ml; P = .73 respectively). The younger group had higher serum calcium levels (11.6 [11.1–12.2] mg/dl) compared with the older group (11.1 [10.7–11.5] mg/dl; P = .01). MIP was performed less frequently on the younger patients (70.6%) compared with older patients (88.7%; P = 0.04). Though the incidence of a single adenoma was somewhat more frequent in older patients (90%; 95% CI = 87–93%) than in younger patients (82%; 95% CI = 57–96%) it was the most frequent cause of PHPT in the younger patients. The younger and older groups did not significantly differ on percent drop from baseline for intraoperative PTH monitoring (81.7 vs 79.3%; P = .46), respectively.
Younger patients with PHPT present with significantly higher serum calcium levels than older patients. However, younger patients are less likely to localize abnormal parathyroid glands on sestamibi or ultrasound. Though younger patients appear to have a higher incidence of hyperplasia compared with older patients, single gland disease is still the overall most frequent cause. Our data suggest that MIP should be more frequently considered in younger patients because of the high incidence of single gland disease.
- Khan AA, Bilezikian JP, Potts JT Jr, Guest Editors for the Third International Workshop on Asymptomatic Primary Hyperparathyroidism. The diagnosis and management of asymptomatic primary hyperparathyroidism revisited. J Clin Endocrinol Metab. 2009;94:333–34.
- Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81:2036–40. CrossRef
- Rapaport D, Ziv Y, Rubin M, Huminer D, Dintsman M. Primary hyperparathyroidism in children. J Pediatr Surg. 1986;21:395–7. CrossRef
- Mannix H Jr. Primary hyperparathyroidism in children. Am J Surg. 1975;129:528–31. CrossRef
- Adam LA, Smith BJ, Calva-Cerqueira D, Howe JR, Lal G. Role for limited neck exploration in young adults with apparently sporadic primary hyperparathyroidism. World J Surg. 2008;32:1518–24. CrossRef
- Sneider MS, Solorzano CC, Montano RE, Anello C, Irvin GL III, Lew JI. Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res. 2009;155:100–3. CrossRef
- Hsu SC, Levine MA. Primary hyperparathyroidism in children and adolescents: the Johns Hopkins Children’s Center experience 1984–2001. J Bone Miner Res. 2002;17:N44–N50.
- Harman CR, van Heerden JA, Farley DR, Grant CS, Thompson GB, Curlee K. Sporadic primary hyperparathyroidism in young patients: a separate disease entity? Arch Surg. 1999;134:651–6. CrossRef
- Irvin GL III, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg. 2004;28:1287–92. CrossRef
- Allo M, Thompson NW, Harness JK, Nishiyama RH. Primary hyperparathyroidism in children, adolescents, and young adults. World J Surg. 1982;6:771–6. CrossRef
- Cronin CS, Reeve TS, Robinson B, Clifton-Bligh P, Guinea A, Delbridge L. Primary hyperparathyroidism in childhood and adolescence. J Pediatr Child Health. 1996;32:397–9. CrossRef
- Venail F, Nicollas R, Morin D, Mackle T, Garnier JM, Triglia JM, et al. Solitary parathyroid adenoma: a rare cause of primary hyperparathyroidism in children. Laryngoscope. 2007;117:946–9. CrossRef
- Kollars J, Zarroug AE, van Heerden J, Lteif A, Stavlo P, Suarez L, et al. Primary hyperparathyroidism in pediatric patients. Pediatrics. 2005;115:974–80. CrossRef
- Bergenfelz A, Lindblom P, Tibbin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236:543–51. CrossRef
- Libansky P, Astl J, Adamek S, Nanka O, Pafko P, Spacková J, et al. Surgical treatment of primary hyperparathyroidism in children: report of 10 cases. Intl J Pediatr Otorhinolaryngol. 2008;72:1177–82. CrossRef
- A Comparison of Outcomes for Younger and Older Adult Patients Undergoing Surgery for Primary Hyperparathyroidism
Annals of Surgical Oncology
Volume 19, Issue 6 , pp 1897-1901
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana
- 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
- 3. Department of Otolaryngology, Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland